Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis

被引：0
作者：
Viola Melone
Annamaria Salvati
Domenico Palumbo
Giorgio Giurato
Giovanni Nassa
Francesca Rizzo
Luigi Palo
Alessandro Giordano
Mariarosaria Incoronato
Mario Vitale
Caterina Mian
Immacolata Di Biase
Stefano Cristiano
Viviana Narciso
Monica Cantile
Annabella Di Mauro
Fabiana Tatangelo
Salvatore Tafuto
Roberta Modica
Claudia Pivonello
Marco Salvatore
Annamaria Colao
Alessandro Weisz
Roberta Tarallo
机构：
[1] University of Salerno,Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”
[2] AOU ‘S. Giovanni di Dio e Ruggi d’Aragona’ University of Salerno,Medical Genomics Program and Division of Oncology
[3] Genome Research Center for Health,Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”
[4] IRCCS Synlab SDN s.p.a,Endocrinology Unit, Department of Medicine (DIMED)
[5] University of Salerno,Pathology Unit
[6] University of Padua,Sarcomas and Rare Tumors Unit
[7] MeriGen Diagnostic & c sas,Department of Clinical Medicine and Surgery, Endocrinology Unit
[8] Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale,undefined
[9] Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale,undefined
[10] Federico II University,undefined
[11] UNESCO Chair for Health Education and Sustainable Development,undefined
[12] Federico II University,undefined
来源：
Journal of Translational Medicine | / 20卷
关键词：
Neuroendocrine neoplasms; Molecular signatures; ATM signaling; Circulating biomarkers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 387 条
[1]  
Oronsky B(2017)Nothing but NET: a review of neuroendocrine tumors and carcinomas Neoplasia 19 991-1002
[2]  
Ma PC(2021)Pancreatic neuroendocrine tumors: molecular mechanisms and therapeutic targets Cancers 26 3063-3072
[3]  
Morgensztern D(2008)One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States J Clin Oncol 31 1770-1786
[4]  
Carter CA(2018)A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal Mod Pathol 451 S29-38
[5]  
Maharjan CK(2007)Hereditary neuroendocrine tumors of the gastroenteropancreatic system Virchows Arch 20 324-36
[6]  
Ear PH(2019)Genetic landscape of somatic mutations in a large cohort of sporadic medullary thyroid carcinomas studied by next-generation targeted sequencing iScience 76 182-188
[7]  
Tran CG(2020)The 2019 WHO classification of tumours of the digestive system Histopathology 59 50-59
[8]  
Howe JR(2020)Medullary thyroid cancer—feature review and update on systemic treatment Acta Clin Croat 4 64-71
[9]  
Chandrasekharan C(2016)Management of advanced medullary thyroid cancer Lancet Diabetes Endocrinol 331 1199-1203
[10]  
Quelle DE(2011)DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors Science 543 65-71
12345678910